AbbVie (ABBV) Inventory Average (2013 - 2026)

AbbVie has disclosed Inventory Average across 14 years of filings, most recently posting $5.0 billion for Q1 2026.

• In Q1 2026, Inventory Average rose 14.85% year-over-year to $5.0 billion; the TTM figure through Mar 2026 stood at $5.0 billion (up 14.85% YoY), while the FY2025 annual figure was $4.6 billion, up 10.29% from the prior year.
• Inventory Average improved to $5.0 billion in Q1 2026, from $4.9 billion in the prior quarter.
• Over the last five years, Inventory Average for ABBV reached as high as $5.0 billion in Q1 2026 and fell as low as $3.3 billion in Q3 2022.
• The 5-year median for Inventory Average is $4.2 billion (2024), against an average of $4.1 billion.
• Annual changes were most pronounced in 2022 — Inventory Average climbed 0.44% — and 2023, when it rose 22.35%.
• A 5-year view of Inventory Average shows it stood at $3.4 billion in 2022, then rose by 19.69% to $4.0 billion in 2023, then rose by 6.82% to $4.3 billion in 2024, then advanced by 14.58% to $4.9 billion in 2025, then increased by 1.12% to $5.0 billion in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $5.0 billion, $4.9 billion, and $4.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.